Assessing of the lidocaine oropharyngeal spray before tracheal intubation on heart rate, blood pressure and arrhythmia in patients undergoing coronary artery bypass graft.

Phase 1

Not yet recruiting

• Conditions: Patients with cardiac ischemia undergoing CABG.

• Registration Number: IRCT20170411033365N3
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients due to cardiac ischemia undergoing CABG

Exclusion Criteria

Patients with a history of previous arrhythmias (Atrial Fibrilation) AF Have
cardiomyopathy of any cause
renal and hepatic impairment,
patients with lidocaine hypersensitivity
patients requiring repeated efforts due to airway obstruction or endotracheal intubation for any reason

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart rate. Timepoint: baseline (T0), one minute before intervention (T1), 30 seconds (T2) and one minute (T3), two (T4), three (T5) ), Four (T6), five (T7), and 10 (T8) after intervention. Method of measurement: Saadat Cardiac and hemodynamic Monitoring for rate monitoring.;Blood Pressure. Timepoint: baseline (T0), one minute before intervention (T1), 30 seconds (T2) and one minute (T3), two (T4), three (T5) ), Four (T6), five (T7), and 10 (T8) after intervention. Method of measurement: Saadat Cardiac and hemodynamic Monitoring for direct blood pressure monitoring.;Arrhythmia. Timepoint: baseline (T0), one minute before intervention (T1), 30 seconds (T2) and one minute (T3), two (T4), three (T5) ), Four (T6), five (T7), and 10 (T8) after intervention. Method of measurement: Saadat Cardiac and hemodynamic Monitoring for arrhythmia detection.